Table 1.

Patients’ characteristics and localization of treated oligometastases

Age (years)	72 (range 56–78)
Concomitant ADT yes/no	3/12
PSA before SBRT	1.99 (range 0.44–11.7)
Initial Gleason Scorea
6 (group1)	1
7a (group 2)	5
7b (group 3)	0
8 (group 4)	4
9 (group 5)	4
Initial PSA (ng/ml) before primary treatment	17.0 (range 4.3–57.2)
Initial N0/N1	9/6
Localization of bone metastases (n = 20)
Pelvis	6
Spine	8
Rib	5
Scapula	1

^ain one patient no GS was available